Valuation: Johnson & Johnson

Capitalization 510B 433B 406B 381B 702B 46,240B 767B 4,729B 1,828B 21,765B 1,913B 1,872B 79,149B P/E ratio 2025 *
20.2x
P/E ratio 2026 * 22.3x
Enterprise value 526B 447B 418B 393B 724B 47,709B 791B 4,879B 1,886B 22,457B 1,973B 1,932B 81,664B EV / Sales 2025 *
5.61x
EV / Sales 2026 * 5.28x
Free-Float
77.08%
Yield 2025 *
2.44%
Yield 2026 * 2.52%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.25%
1 week+6.34%
Current month+3.62%
1 month+7.43%
3 months+20.86%
6 months+38.13%
Current year+48.26%
More quotes
1 week 199.9
Extreme 199.905
214.46
1 month 195.9
Extreme 195.9
214.46
Current year 140.68
Extreme 140.68
214.46
1 year 140.68
Extreme 140.68
214.46
3 years 140.68
Extreme 140.68
214.46
5 years 140.68
Extreme 140.68
214.46
10 years 94.28
Extreme 94.28
214.46
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 02/01/2022
Director of Finance/CFO 58 30/06/2018
Chief Tech/Sci/R&D Officer 60 31/07/2024
Director TitleAgeSince
Director/Board Member 72 22/10/2009
Director/Board Member 61 14/10/2013
Director/Board Member 70 08/06/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.26%+6.34%+49.05%+20.80% 510B
+2.84%+6.32%+36.15%+194.61% 920B
+1.58%+1.86%+32.41%+39.34% 395B
+1.61%+1.32%+25.60%+6.43% 340B
+1.25%+0.25%+29.34%+19.82% 278B
+1.65%+0.56%+21.86%+26.73% 254B
+0.28%+0.44%-0.69%-9.36% 249B
-1.48%+5.82%-59.29%-32.12% 224B
+1.63%+0.45%+21.07%+21.24% 171B
+1.01%-0.36%+31.18%+39.47% 149B
Average +1.21%+0.45%+18.67%+32.70% 349.14B
Weighted average by Cap. +1.57%+1.07%+25.29%+62.92%
See all sector performances

Financials

2025 *2026 *
Net sales 93.76B 79.72B 74.6B 70.06B 129B 8,505B 141B 870B 336B 4,003B 352B 344B 14,557B 98.48B 83.74B 78.36B 73.59B 136B 8,933B 148B 913B 353B 4,205B 370B 362B 15,291B
Net income 24.7B 21B 19.65B 18.46B 34B 2,240B 37.15B 229B 88.56B 1,055B 92.67B 90.72B 3,835B 23.45B 19.94B 18.66B 17.52B 32.28B 2,127B 35.27B 217B 84.06B 1,001B 87.97B 86.12B 3,640B
Net Debt 16.2B 13.78B 12.89B 12.11B 22.3B 1,470B 24.37B 150B 58.09B 692B 60.79B 59.51B 2,515B 10.33B 8.79B 8.22B 7.72B 14.23B 937B 15.54B 95.85B 37.05B 441B 38.77B 37.95B 1,604B
More financial data * Estimated data
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2024, Johnson & Johnson has 64 manufacturing facilities located in the United States (23), North America (7), Europe (21), Africa and Asia/Pacific (13). The United States accounts for 56.6% of net sales.
Employees
138,100
More about the company
Date Price Change Volume
15/12/25 214.47 $ +1.37% 4,187,964
12/12/25 211.58 $ +0.75% 6,922,683
11/12/25 210.01 $ +1.68% 9,008,960
10/12/25 206.54 $ +3.29% 11,599,785
09/12/25 199.96 $ -0.82% 7,509,402

Delayed Quote Nyse, December 15, 2025 at 06:54 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
211.58USD
Average target price
207.08USD
Spread / Average Target
-2.12%
Consensus

Quarterly revenue - Rate of surprise